Scarica l'app Stockscreener
18.05
3.38%
0.59
Pre-mercato:
18.00
-0.05
-0.28%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$17.46
Aprire:
$17.505
Volume 24 ore:
12.64M
Relative Volume:
1.32
Capitalizzazione di mercato:
$9.29B
Reddito:
$10.89B
Utile/perdita netta:
$-241.00M
Rapporto P/E:
-67.96
EPS:
-0.2656
Flusso di cassa netto:
$340.00M
1 W Prestazione:
-5.15%
1M Prestazione:
-18.95%
6M Prestazione:
-26.30%
1 anno Prestazione:
-49.65%
Intervallo 1D:
$17.29
$18.26
Intervallo di 1 settimana:
$17.00
$18.96
Portata 52W:
$17.00
$35.77
Baxter International Inc Stock (BAX) Company Profile
Nome
Baxter International Inc
Settore
Industria
Telefono
(224) 948-2000
Indirizzo
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, RMD, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
18.05 | 9.29B | 10.89B | -241.00M | 340.00M | -0.2656 |
|
ISRG
Intuitive Surgical Inc
|
492.87 | 175.03B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
163.17 | 46.42B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
80.77 | 39.37B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
240.15 | 34.98B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
42.39 | 34.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-31 | Downgrade | Argus | Buy → Hold |
| 2025-08-04 | Downgrade | Stifel | Buy → Hold |
| 2025-08-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-02-26 | Ripresa | Goldman | Buy |
| 2025-02-24 | Aggiornamento | Argus | Hold → Buy |
| 2025-02-20 | Ripresa | Barclays | Overweight |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-06-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Goldman | Neutral → Sell |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-18 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-18 | Reiterato | Raymond James | Outperform |
| 2022-02-18 | Reiterato | Stifel | Buy |
| 2022-02-18 | Reiterato | UBS | Neutral |
| 2022-02-18 | Reiterato | Wells Fargo | Overweight |
| 2022-02-11 | Iniziato | Goldman | Neutral |
| 2022-01-07 | Ripresa | Citigroup | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-09-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Downgrade | UBS | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-09-04 | Downgrade | Argus | Buy → Hold |
| 2020-06-24 | Iniziato | Oppenheimer | Outperform |
| 2020-03-19 | Aggiornamento | Stifel | Hold → Buy |
| 2020-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-02 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-05-17 | Ripresa | Piper Jaffray | Overweight |
| 2018-02-06 | Reiterato | Citigroup | Neutral |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
Mostra tutto
Baxter International Inc Borsa (BAX) Ultime notizie
Why Baxter International Inc. stock remains undervaluedJuly 2025 Reactions & Community Driven Trade Alerts - mfd.ru
Citigroup Lowers Price Target for Baxter International (BAX) Ami - GuruFocus
Baxter International (NYSE:BAX) Given New $19.00 Price Target at Citigroup - MarketBeat
Russell Investments Group Ltd. Has $57.24 Million Stock Position in Baxter International Inc. $BAX - MarketBeat
Baxter International Sees Unusually High Options Volume (NYSE:BAX) - MarketBeat
[Latest] Global Intravenous Infusion Pump Market Size/Share Worth USD 14.02 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Baxter International (NYSE:BAX) Sets New 52-Week LowWhat's Next? - MarketBeat
Baxter International stock hits 52-week low at $17.26 - Investing.com
Blood Tubing Set Market Is Going to Boom Rapidly | Baxter International • Terumo Corporation • Fresenius Kabi - openPR.com
Baxter International Inc. $BAX Stake Increased by Gamco Investors INC. ET AL - MarketBeat
Gabelli Funds LLC Has $15.87 Million Stock Position in Baxter International Inc. $BAX - MarketBeat
Is Baxter International Inc. stock a contrarian buyPortfolio Profit Report & Daily Chart Pattern Signals - Naître et grandir
Is Baxter International (BAX) Pricing In Too Much Bad News After Its Sharp Share Price Fall - simplywall.st
Baxter Reshapes Portfolio With Kidney Spin Off And Margin Focus - Yahoo Finance
How Baxter International Inc. stock valuations compare to rivalsOil Prices & Weekly Setup with ROI Potential - Naître et grandir
Will Baxter International Inc. stock recover faster than peersTrade Volume Summary & Real-Time Volume Triggers - Naître et grandir
Why Baxter International Inc. stock could be next big winnerExit Point & AI Forecasted Entry and Exit Points - Naître et grandir
Baxter International Inc (BAX) Shares Gap Down to $17.875 on Mar 6 - GuruFocus
Sticking With Baxter At The Lows (NYSE:BAX) - Seeking Alpha
Reassessing Baxter International (BAX) Valuation After Recent Share Price Weakness - Sahm
Q1 EPS Estimate for Baxter International Lowered by Analyst - MarketBeat
Baxter Joins the National Infusion Collaborative to Advance Infusion Safety and Best Practices - The National Law Review
Global Hollow Fiber Dialyzer Market Size, Growth, Trends & - openPR.com
Baxter International: Spin-Off Nears As Wall Street Re-Rates The Stock - AD HOC NEWS
Baxter International Inc. (NYSE:BAX) Short Interest Update - MarketBeat
Baxter International (NYSE:BAX) Upgraded at Zacks Research - MarketBeat
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & SuppliesDiversified Stocks - Yahoo! Finance Canada
Baxter International Inc (BAX) Trading Down 4.86% on Mar 2 - GuruFocus
Baxter International Inc. (BAX) Stock Analysis: Navigating Opportunities with a 6.20% Potential Upside - DirectorsTalk Interviews
DNB Asset Management AS Raises Stock Holdings in Baxter International Inc. $BAX - MarketBeat
Analysts Offer Insights on Healthcare Companies: Baxter International (BAX), Nautilus Biotechnolgy (NAUT) and Delcath Systems (DCTH) - The Globe and Mail
BAX SEC FilingsBaxter Intl Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Understanding Baxter International's Role in MedTech - www.whatjobs.com
Baxter International Inc.: - marketscreener.com
Baxter International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Baxter at Citi’s MedTech Day: Strategic Shifts Amidst Challenges - Investing.com
Baxter International Inc To Go Ex-Dividend On February 27th, 2026 With 0.01 USD Dividend Per Share - 富途牛牛
Siemens, Baxter, Hilton & more dividends 2026 • Vienna Stock Exchange - Wiener Börse
Ex-Dividend Reminder: MGE Energy, Labcorp Holdings and Baxter International - Nasdaq
Argus Research Maintains Baxter International Inc(BAX.US) With Hold Rating - 富途牛牛
Infusion Stand Market Is Going to Boom | BD • Baxter International • Smiths Medical - openPR.com
Baxter Investors Face a Test of Patience Amid Corporate Overhaul - AD HOC NEWS
Is Baxter International (BAX) Pricing In Its Turnaround After Years Of Share Price Weakness? - simplywall.st
Baxter International's $3 Billion Sales Base Facing Earnings Pressure - Smartkarma
Baxter is one of the S&P 500’s worst performers today. Earnings were brutal. - MSN
Baxter’s Ongoing Losses And Impairments Test The Investment Narrative - Yahoo Finance
Baxter International Inc. (BAX) Stock Analysis: Navigating Through Challenges with Strategic Resilience - DirectorsTalk Interviews
Is Baxter International Inc (BAX) Set to Underperform? Analyzing the Factors Limiting Growth - GuruFocus
Baxter’s Profit Strains Put Execution And Valuation Story Under Scrutiny - simplywall.st
Baxter International Inc Azioni (BAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.03%
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):